Brain‐derived neurotrophic factor and nerve growth factor correlate with T‐cell activation in primary Sjögren's syndrome

References

• Aloe L., Bracci‐Laudiero L., Bonini S., Manni L. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy 1997; 52: 883–94
   PubMed Web of Science ®Google Scholar
• Tuveri M. A., Passiu G., Mathieu A., Aloe L. Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis. Clin Exp Rheumatol 1993; 11: 319–22
   PubMed Web of Science ®Google Scholar
• Aloe L., Tuveri M. A., Carcassi U., Levi‐Montalcini R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum 1992; 35: 351–5
   PubMed Web of Science ®Google Scholar
• Falcini F., Matucci Cerinic M., Lombardi A., Generini S., Pignone A., Tirassa P., et al. Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis. Ann Rheum Dis 1996; 55: 745–8
   PubMedGoogle Scholar
• Bracci‐Laudiero L., Lundeberg T., Stenfors C., Theodorsson E., Tirassa P., Aloe L. Modification of lymphoid and brain nerve growth factor levels in systemic lupus erythematosus mice. Neurosci Lett 1996; 204: 13–16
   PubMedGoogle Scholar
• Hattori A., Tanaka E., Murase K., Ishida N., Chatani Y., Tsujimoto M., et al. Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non‐neuronal cells. J Biol Chem 1993; 268: 2577–82
   PubMed Web of Science ®Google Scholar
• Besser M., Wank R. Cutting edge: clonally restricted production of the neurotrophins brain‐derived neurotrophic factor and neurotrophin‐3 mRNA by human immune cells and Th1/Th2‐polarized expression of their receptors. J Immunol 1999; 162: 6303–6
   PubMedGoogle Scholar
• Torcia M., Bracci‐Laudiero L., Lucibello M., Nencioni L., Labardi D., Rubartelli A., et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996; 85: 345–56
   PubMed Web of Science ®Google Scholar
• Otten U., Ehrhard P., Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 1989; 86: 10059–63
   PubMed Web of Science ®Google Scholar
• Pearse R. N., Swendeman S. L., Li Y., Rafii D., Hempstead B. L. A neurotrophin axis in myeloma: TrkB and BDNF promote tumor‐cell survival. Blood 2005; 105: 4429–36
   PubMed Web of Science ®Google Scholar
• Fauchais A. L., Lalloué F., Lise M., Preud'Homme J., Vidal E., Jauberteau M. O. Role of endogenous brain‐derived‐neurotrophic factor and sortilin in B cell survival. J Immunol 2008, in press
   PubMedGoogle Scholar
• Thorpe L. W., Perez‐Polo J. R. The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J Neurosci Res 1987; 18: 134–9
   PubMed Web of Science ®Google Scholar
• Ehrhard P. B., Erb P., Graumann U., Schmutz B., Otten U. Expression of functional trk tyrosine kinase receptors after T cell activation. J Immunol 1994; 152: 2705–9
   PubMed Web of Science ®Google Scholar
• Thorpe L. W., Werrbach‐Perez K., Perez‐Polo J. R. Effects of nerve growth factor on the expression of interleukin‐2 receptors on cultured human lymphocytes. Ann N Y Acad Sci 1987; 496: 310–11
   PubMed Web of Science ®Google Scholar
• Lambiase A., Bracci‐Laudiero L., Bonini S., Starace G., D'Elios M. M., De Carli M., et al. Human CD4+ T cell clones produce and release nerve growth factor and express high‐affinity nerve growth factor receptors. J Allergy Clin Immunol 1997; 100: 408–14
   PubMed Web of Science ®Google Scholar
• Kerschensteiner M., Gallmeier E., Behrens L., Leal V. V., Misgeld T., Klinkert W. E., et al. Activated human T cells, B cells, and monocytes produce brain‐derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J Exp Med 1999; 189: 865–70
   PubMed Web of Science ®Google Scholar
• Maroder M., Bellavia D., Meco D., Napolitano M., Stigliano A., Alesse E., et al. Expression of trKB neurotrophin receptor during T cell development. Role of brain‐derived neurotrophic factor in immature thymocyte survival. J Immunol 1996; 157: 2864–72
   PubMedGoogle Scholar
• Haugen A. J., Peen E., Hulten B., Johannessen A. C., Brun J. G., Halse A. K., et al. Estimation of the prevalence of primary Sjögren's syndrome in two age‐different community‐based populations using two sets of classification criteria: the Hordaland Health Study. Scand J Rheumatol 2008; 37: 30–4
   PubMed Web of Science ®Google Scholar
• Novljan M. P., Rozman B., Jerse M., Rotar Z., Vidmar G., Kveder T., et al. Comparison of the different classification criteria sets for primary Sjögren's syndrome. Scand J Rheumatol 2006; 35: 463–7
   PubMed Web of Science ®Google Scholar
• Manthorpe R., Bredberg A., Henriksson G., Larsson A. Progress and regression within primary Sjögren's syndrome. Scand J Rheumatol 2006; 35: 1–6
   PubMed Web of Science ®Google Scholar
• Zeher M., Szodoray P., Gyimesi E., Szondy Z. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome. Arthritis Rheum 1999; 42: 1673–81
   PubMed Web of Science ®Google Scholar
• Ichikawa Y., Shimizu H., Yoshida M., Arimori S. Activation of T cell subsets in the peripheral blood of patients with Sjögren's syndrome. Multicolor flow cytometric analysis. Arthritis Rheum 1990; 33: 1674–81
   PubMedGoogle Scholar
• Ichikawa Y., Shimizu H., Yoshida M., Arimori S. Activation antigens expressed on T‐cells of the peripheral blood in Sjögren's syndrome and rheumatoid arthritis. Clin Exp Rheumatol 1990; 8: 243–9
   PubMedGoogle Scholar
• Ramos H. L., Valencia‐Pacheco G., Alcocer‐Varela J. Constitutive STAT3 activation in peripheral CD3(+) cells from patients with primary Sjögren's syndrome. Scand J Rheumatol 2008; 37: 35–9
   PubMed Web of Science ®Google Scholar
• Szodoray P., Gal I., Barath S., Aleksza M., Horvath I. F., Gergely P. Jr., et al. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T‐cell subsets and inflammatory cytokines. Scand J Rheumatol 2008; 37: 205–12
   PubMed Web of Science ®Google Scholar
• Strom T., Evrin P. E., Karlsson A. Serum beta‐2‐microglobulin in Sjögren's syndrome. Scand J Rheumatol 1978; 7: 97–100
   PubMed Web of Science ®Google Scholar
• Groom J., Kalled S. L., Cutler A. H., Olson C., Woodcock S. A., Schneider P., et al. Association of BAFF/BLYS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 2002; 109: 59–68
   PubMed Web of Science ®Google Scholar
• Gottenberg J. E., Busson M., Cohen‐Solal J., Lavie F., Abbed K., Kimberly R. P., et al. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren's syndrome. Ann Rheum Dis 2005; 64: 1050–5
   PubMedGoogle Scholar
• Gottenberg J. E., Aucouturier F., Goetz J., Sordet C., Jahn I., Busson M., et al. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjögren's syndrome. Ann Rheum Dis 2007; 66: 23–7
   PubMed Web of Science ®Google Scholar
• Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H. M., Alexander E. L., Carsons S. E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 2002; 61: 554–8
   PubMed Web of Science ®Google Scholar
• Yang Z. F., Ho D. W., Lau C. K., Tam K. H., Lam C. T., Yu W. C., et al. Significance of the serum brain‐derived neurotrophic factor and platelets in hepatocellular carcinoma. Oncol Rep 2006; 16: 1237–43
   PubMed Web of Science ®Google Scholar
• Garcia‐Carrasco M., Ramos‐Casals M., Rosas J., Pallares L., Calvo‐Alen J., Cervera R., et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 2002; 81: 270–80
   PubMed Web of Science ®Google Scholar
• Fauchais A., Lambert M., Dubucquoi S., Hachulla E., Pasturel U., Queyrel V., et al. Inaugural Raynaud's phenomenon is associated with a multisystemic involvement during follow‐up in primary Sjögren syndrome – a report of 162 patients. International Journal of Angiology 2004; 13: 71–74
   Google Scholar
• Aloe L., Bracci‐Laudiero L., Alleva E., Lambiase A., Micera A., Tirassa P. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc Natl Acad Sci USA 1994; 91: 10440–4
   PubMed Web of Science ®Google Scholar
• Lin‐Lee Y. C., Pham L. V., Tamayo A. T., Fu L., Zhou H. J., Yoshimura L. C., et al. Nuclear localization in the biology of the CD40 receptor in normal and neoplastic human B lymphocytes. J Biol Chem 2006; 281: 18878–87
   PubMed Web of Science ®Google Scholar
• Brodie C., Oshiba A., Renz H., Bradley K., Gelfand E. W. Nerve growth‐factor and anti‐CD40 provide opposite signals for the production of IgE in interleukin‐4‐treated lymphocytes. Eur J Immunol 1996; 26: 171–8
   PubMedGoogle Scholar
• Ricci A., Mariotta S., Saltini C., Falasca C., Giovagnoli M. R., Mannino F., et al. Neurotrophin system activation in bronchoalveolar lavage fluid immune cells in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 186–94
   PubMedGoogle Scholar
• Moalem G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I. R., et al. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun 2000; 15: 331–45
   PubMed Web of Science ®Google Scholar
• Ehrhard P. B., Erb P., Graumann U., Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4‐positive T‐cell clones. Proc Natl Acad Sci USA 1993; 90: 10984–8
   PubMed Web of Science ®Google Scholar
• Namura K., Hasegawa G., Egawa M., Matsumoto T., Kobayashi R., Yano T., et al. Relationship of serum brain‐derived neurotrophic factor level with other markers of disease severity in patients with atopic dermatitis. Clin Immunol 2007; 122: 181–6
   PubMed Web of Science ®Google Scholar
• Viallard J. F., Bloch‐Michel C., Neau‐Cransac M., Taupin J. L., Garrigue S., Miossec V., et al. HLA‐DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus. Clin Exp Immunol 2001; 125: 485–91
   PubMed Web of Science ®Google Scholar